Cargando…

Efficacy and safety associated with the use of the Surfacer(®) Inside-Out(®) Access Catheter System: Results from a prospective, multicenter Food and Drug Administration–approved Investigational Device Exemption study

PURPOSE: Thoracic central venous obstruction is commonly associated with the use of central venous catheters. The Surfacer System to Facilitate Access in Venous Occlusions Study was an Food and Drug Administration–approved US Investigational Device Exemption study designed to evaluate the performanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Razavi, Mahmood K, Peden, Eric K, Sorial, Ehab, Ross, John R, Aruny, John E, Pflederer, Timothy A, Wasse, Haimanot, Haskal, Ziv J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897784/
https://www.ncbi.nlm.nih.gov/pubmed/32597356
http://dx.doi.org/10.1177/1129729820937121
_version_ 1783653736980152320
author Razavi, Mahmood K
Peden, Eric K
Sorial, Ehab
Ross, John R
Aruny, John E
Pflederer, Timothy A
Wasse, Haimanot
Haskal, Ziv J
author_facet Razavi, Mahmood K
Peden, Eric K
Sorial, Ehab
Ross, John R
Aruny, John E
Pflederer, Timothy A
Wasse, Haimanot
Haskal, Ziv J
author_sort Razavi, Mahmood K
collection PubMed
description PURPOSE: Thoracic central venous obstruction is commonly associated with the use of central venous catheters. The Surfacer System to Facilitate Access in Venous Occlusions Study was an Food and Drug Administration–approved US Investigational Device Exemption study designed to evaluate the performance and safety of the Surfacer System when used to facilitate central venous access in patients with thoracic central venous obstruction. METHODS: Thirty patients were enrolled in this prospective, multicenter, single-arm study between December 2017 and May 2019. Device performance and adverse events were collected peri-procedurally and at discharge. Enrollment included 15 female and 15 male subjects with a mean age of 55.5 ± 12.9 (range: 30–79) years. Twenty-eight patients (93.3%) required central venous access for hemodialysis access. Locations of thoracic central venous obstruction were graded from 1 to 4 based on severity and extension of venous occlusions. Seven patients (23.3%) had type 1, 6 (20.0%) type 2, 16 (53.3%) type 3, and 1 (3.3%) type 4 obstruction. RESULTS: Successful central venous catheter placement was achieved in 27 of 30 patients (90.0%). The procedure was discontinued in three (10.0%) due to tortuous anatomy discovered intraprocedurally. All 27 patients with successful CVC placement achieved adequate catheter patency and tip positioning with a mean overall procedural time and time to achieve central venous access with the Surfacer System being 44.1 ± 30.6 and 19.1 ± 25.1 min, respectively. There were no device-related adverse events or catheter malposition. CONCLUSION: The results of the SAVEUS Study confirm the safety and efficacy of the Surfacer System and the Inside-Out procedure when used for the placement of right-sided central venous access in patients with thoracic central venous obstruction.
format Online
Article
Text
id pubmed-7897784
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-78977842021-03-10 Efficacy and safety associated with the use of the Surfacer(®) Inside-Out(®) Access Catheter System: Results from a prospective, multicenter Food and Drug Administration–approved Investigational Device Exemption study Razavi, Mahmood K Peden, Eric K Sorial, Ehab Ross, John R Aruny, John E Pflederer, Timothy A Wasse, Haimanot Haskal, Ziv J J Vasc Access Original Research Articles PURPOSE: Thoracic central venous obstruction is commonly associated with the use of central venous catheters. The Surfacer System to Facilitate Access in Venous Occlusions Study was an Food and Drug Administration–approved US Investigational Device Exemption study designed to evaluate the performance and safety of the Surfacer System when used to facilitate central venous access in patients with thoracic central venous obstruction. METHODS: Thirty patients were enrolled in this prospective, multicenter, single-arm study between December 2017 and May 2019. Device performance and adverse events were collected peri-procedurally and at discharge. Enrollment included 15 female and 15 male subjects with a mean age of 55.5 ± 12.9 (range: 30–79) years. Twenty-eight patients (93.3%) required central venous access for hemodialysis access. Locations of thoracic central venous obstruction were graded from 1 to 4 based on severity and extension of venous occlusions. Seven patients (23.3%) had type 1, 6 (20.0%) type 2, 16 (53.3%) type 3, and 1 (3.3%) type 4 obstruction. RESULTS: Successful central venous catheter placement was achieved in 27 of 30 patients (90.0%). The procedure was discontinued in three (10.0%) due to tortuous anatomy discovered intraprocedurally. All 27 patients with successful CVC placement achieved adequate catheter patency and tip positioning with a mean overall procedural time and time to achieve central venous access with the Surfacer System being 44.1 ± 30.6 and 19.1 ± 25.1 min, respectively. There were no device-related adverse events or catheter malposition. CONCLUSION: The results of the SAVEUS Study confirm the safety and efficacy of the Surfacer System and the Inside-Out procedure when used for the placement of right-sided central venous access in patients with thoracic central venous obstruction. SAGE Publications 2020-06-27 2021-01 /pmc/articles/PMC7897784/ /pubmed/32597356 http://dx.doi.org/10.1177/1129729820937121 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research Articles
Razavi, Mahmood K
Peden, Eric K
Sorial, Ehab
Ross, John R
Aruny, John E
Pflederer, Timothy A
Wasse, Haimanot
Haskal, Ziv J
Efficacy and safety associated with the use of the Surfacer(®) Inside-Out(®) Access Catheter System: Results from a prospective, multicenter Food and Drug Administration–approved Investigational Device Exemption study
title Efficacy and safety associated with the use of the Surfacer(®) Inside-Out(®) Access Catheter System: Results from a prospective, multicenter Food and Drug Administration–approved Investigational Device Exemption study
title_full Efficacy and safety associated with the use of the Surfacer(®) Inside-Out(®) Access Catheter System: Results from a prospective, multicenter Food and Drug Administration–approved Investigational Device Exemption study
title_fullStr Efficacy and safety associated with the use of the Surfacer(®) Inside-Out(®) Access Catheter System: Results from a prospective, multicenter Food and Drug Administration–approved Investigational Device Exemption study
title_full_unstemmed Efficacy and safety associated with the use of the Surfacer(®) Inside-Out(®) Access Catheter System: Results from a prospective, multicenter Food and Drug Administration–approved Investigational Device Exemption study
title_short Efficacy and safety associated with the use of the Surfacer(®) Inside-Out(®) Access Catheter System: Results from a prospective, multicenter Food and Drug Administration–approved Investigational Device Exemption study
title_sort efficacy and safety associated with the use of the surfacer(®) inside-out(®) access catheter system: results from a prospective, multicenter food and drug administration–approved investigational device exemption study
topic Original Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897784/
https://www.ncbi.nlm.nih.gov/pubmed/32597356
http://dx.doi.org/10.1177/1129729820937121
work_keys_str_mv AT razavimahmoodk efficacyandsafetyassociatedwiththeuseofthesurfacerinsideoutaccesscathetersystemresultsfromaprospectivemulticenterfoodanddrugadministrationapprovedinvestigationaldeviceexemptionstudy
AT pedenerick efficacyandsafetyassociatedwiththeuseofthesurfacerinsideoutaccesscathetersystemresultsfromaprospectivemulticenterfoodanddrugadministrationapprovedinvestigationaldeviceexemptionstudy
AT sorialehab efficacyandsafetyassociatedwiththeuseofthesurfacerinsideoutaccesscathetersystemresultsfromaprospectivemulticenterfoodanddrugadministrationapprovedinvestigationaldeviceexemptionstudy
AT rossjohnr efficacyandsafetyassociatedwiththeuseofthesurfacerinsideoutaccesscathetersystemresultsfromaprospectivemulticenterfoodanddrugadministrationapprovedinvestigationaldeviceexemptionstudy
AT arunyjohne efficacyandsafetyassociatedwiththeuseofthesurfacerinsideoutaccesscathetersystemresultsfromaprospectivemulticenterfoodanddrugadministrationapprovedinvestigationaldeviceexemptionstudy
AT pflederertimothya efficacyandsafetyassociatedwiththeuseofthesurfacerinsideoutaccesscathetersystemresultsfromaprospectivemulticenterfoodanddrugadministrationapprovedinvestigationaldeviceexemptionstudy
AT wassehaimanot efficacyandsafetyassociatedwiththeuseofthesurfacerinsideoutaccesscathetersystemresultsfromaprospectivemulticenterfoodanddrugadministrationapprovedinvestigationaldeviceexemptionstudy
AT haskalzivj efficacyandsafetyassociatedwiththeuseofthesurfacerinsideoutaccesscathetersystemresultsfromaprospectivemulticenterfoodanddrugadministrationapprovedinvestigationaldeviceexemptionstudy